Auro pharma has tested 685 and price was rejected. Slowly it is again going to test 685 and in case managed to break through then the next target is 705. On the lower side 645 is the short term base.
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.